With Glooko Logbook Charts , people with diabetes can now graph their blood glucose readings to better understand trends.

PALO ALTO, Calif. & LONDON, U.K .–June 27,2012 – Glooko, Inc ., makers of an innovative mobile logbook solution for people with diabetes , today officially launches its Glooko™ Logbook Charts in the European Union and Glooko Logbook History Report in the US, Canada and European Union. The addition of charts take s monitoring blood glucose readings with the Glooko Logbook app a step further, giving people with diabetes a more in – depth analysis of their blood glucose data through graphs oriented by time of day or by date.

According to the World Health Organization , there are over 20 million people diagnosed with diabetes in the European Union . Today’s introduction of Glooko Logbook Charts in the European Union will help people with diabetes monitor their blood glucose readings to gain better control of their diabetes and become better self – managers of the ir condition. Visualizing and understanding the effects of actions and treatments on blood glucose values can ultimately help people gain control , providing them insight on how to modify their lifestyle.  Additionally, this understanding can lead to more productive conversations with healthcare professionals ( 1)

By simply connecting the Glooko MeterSync Cable to one of the 11 compatible blood glucose meters and an iOS device, users can quickly download all of their readings directly into the Glooko Logbook app with a single click. This eliminates user error and saves time versus alternative s that depend on manual entry or paper logbooks, making Glooko one of the easiest and most accurate ways to monitor blood glucose readings on a smartphone. With Glooko Logbook on their phone, users can take notes about carbs, insulin and wellness factors — on the go in real time .

“As an endocrinologist working with patients for 25 years , I know the value of an accurate and thorough logbook and how it’s key to a physician’s ability to better guide their patient’s diabetes treatment,” says Dr. Michael Greenfield, chief medical officer at Glooko. “At Glooko, we are creating a solution that is easy and intuitive with the hope that we can help change behaviors behind managing diabetes . When patients share their Glooko Logbook Charts with their physician, together they can analyze the impact of specific treatments on their blood glucose readings. Those charts are a great catalyst to create an open dialogue about trends and readings out of range. ”

Graphs and statistics are automatically created when users import their Glooko Logbook CSV file into Excel® with Glooko Logbook Charts . The spreadsheet can be downloaded for free here: https://glooko.com/en/product/logbook/.

Glooko Logbook Charts – available in the E.U. only
Glooko Logbook Charts provide s three charting options for users : chart by time of day, chart by date , and chart by analysis of time of day. This gives people a comprehensive way to compare blood glucose readings over time so they can view how different factors — from diet and exercise to medication and treatments — impact their readings.

Some additional benefits of Glooko Logbook Charts include :

Glooko Logbook History Report – available in the U.S., Canada and E.U.
In addition to Glooko Logbook Charts, Glooko also releases its new Glooko Logbook History Report. The feature creates a consolidated record of all of the data in the Glooko Logbook app — including blood glucose readings, meal tags, carbs, insulin and comments — aligned by date and time.

“We’ve entered an era where the intersection between technology and healthcare has come to life,” says Glooko Co – founder and Chairman , Yogen Dalal. “ Glooko bridges blood glucose meters with the smartphones we’re all carrying around with us. Ultimately , we’ re hoping to give people with diabetes more context and meaning behind their blood glucose readings to help them control their condition .

” Glooko is backed by some heavy hitters in Silicon Valley , including former Facebook, Apple, and Cisco executives. Together they are committed to helping people with diabetes live life while effortlessly managing their diabetes.

Currently, Glooko Logbook Charts is only available in the European Union where Glooko products are sold on Amazon.co.uk. Glooko plans to submit Glooko Logbook Charts to the regulatory authorities in the U . S . and Canada as well, so that its customers in the se countries can also enjoy the new features .

The Glooko Logbook app is free and available for download in the iTunes App Store : http://itunes.apple.com/us/app/glooko-logbook-diabetes-take/id471942748?mt=8

To download Glooko Logbook Charts , Glooko Logbook History Report , and learn more about compatible meters, visit: https://glooko.com/en/product/logbook/

To purchase the Glooko MeterSync Cable and Glooko IR Adapter , and learn more about pricing, visit: https://glooko.com/en/purchase/logbook/

About Glooko
Glooko ™ is an innovative Silicon Valley startup with a unique solution for people with diabetes. In November 2011, Glooko launched the Glooko MeterSync Cable and Glooko Logbook app for iOS devices. The products enable people with diabetes to easily collect and view the information needed to help them successfully control their blood glucose readings. It has been hailed by users and industry influencers for its ease – of – use and ability to provide context to daily data collected by people with diabetes. The company was founded in June 2010 by technologist Yogen Dalal, diabetes healthcare executive , Anita Mathew , and mobile and web app developer, Sundeep Madra. Endocrinol ogist, Michael S. Greenfield, M.D. , is chief medical officer. Each founder and many on the Glooko team have a personal connection to diabetes. This is just the beginning of the mission to help people with diabetes live life while effortlessly managing their diabetes.  For more information: www.glooko.com

Media Contact
Olivia Gallion
VSCpr for Glooko
[email protected]
415-677-9125 x 204

(1)Source: Knowler WC, Barrett-Connor E, Fowler SE, et al. (2002). New EnglandJournal of Medicine 346 (393).

Roche Diabetes Care and Glooko, Inc. join forces to provide ACCU-CHEK meter users an easy solution to download their meter readings directly into their Apple iPhone® or iPod touch.

Palo Alto, Calif. and Indianapolis, Ind., May 30 , 2012 — Glooko, Inc., makers of an innovative diabetes logbook solution, and Roche Diabetes Care, makers of ACCU-CHEK blood glucose monitoring systems, insulin pumps and information management solutions, today announced their co-promotion of the Glooko Logbook solution in the U.S . With the introduction of the Glooko IR Adapter, ACCU-CHEK customers who prefer to manage their diabetes on their iPhone or iPod touch can now use the Glooko MeterSync Cable and the Glooko Logbook app . With the Glooko products, not only can ACCU-CHEK users download their blood glucose readings from their meter, but they can also add notes and view the information anytime, anywhere on their mobile devices to help them monitor their blood glucose values.

The new Glooko IR Adapter connects to the Glooko MeterSync Cable to download blood glucose readings from ACCU-CHEK meters into the Glooko Logbook app on the consumer’s iPhone and iPod touch . The Glooko IR Adapter is compatible with the following ACCU-CHEK systems: ACCU-CHEK Aviva, ACCU-CHEK Compact Plus, and the recently released ACCU-CHEK Nano SmartView Meter System.

“Our goal at Roche is to give people with diabetes the tools they need to manage their diabetes in a way that is convenient for them,” said Marc Gibeley, Head of Roche Diabetes Care North America. “We want to give our customers choices, and the Glooko products nicely complement our current suite of information management solutions . It’s important for people to see their blood sugar patterns, and now our customers who prefer mobile Apple iOS devices can download readings and review trends on their iPhone or iPod touch to help them better manage their life with diabetes.”

Consumers can download their blood glucose readings seamlessly and within seconds. They simply connect the Glooko MeterSync Cable and Glooko IR Adapter to their iPhone or iPod touch and position it near their ACCU-CHEK monitoring system to enable the transfer of data via infrared . The ir readings are entered into Glooko Logbook app , where user s can take notes on the go, review trends and share their logbook with their healthcare professionals.

“As a nimble Silicon Valley company , we were able to very quickly design and manufacture an infrared solution for the Glooko IR Adapter in order to bring the Glooko Logbook to ACCU-CHEK customers . We are thrilled to join forces with Roche, a company with a 30-year legacy of innovation that makes a difference in people’s lives, bringing convenience and steady improvements to helping people manage their glucose levels,” said Anita Mathew, Co-Founder and VP Business Development at Glooko. “Giving people control of their diabetes and helping them become better self-managers is something accomplished with convenient testing and simple tools to understand the myriad variables that have an impact on their blood glucose. The ACCU – CHEK blood glucose monitoring systems and Glooko Logbook solution go hand-in-hand to help achieve this.”

The Glooko MeterSync Cable and Glooko IR Adapter are available for purchase on Amazon.com . Pricing for the products are listed on the Glooko website at www.glooko.com/purchase. The Glooko Logbook app is available for free on the App Store and compatible with iPhone and iPod touch devices.

In addition to the Glooko IR Adapter , today Glooko also released a new version of the Glooko Logbook app . With improvements to the Share function , now users can easily share their logbook either by 2-week or 1-month PDFs via email or efax, AirPrint, and open the PDF in other apps on their iOS devices. As Glooko continues to innovate, future plans include more smartphone and tablet compatibility as well as geographies and solutions that encompass beyond FDA Class.

Diabetes is quickly becoming a global epidemic with far – reaching social, health and economic implications. In the US, 1 in 12 individuals are living with diabetes-18.8M individuals who have been diagnosed and 7M who have not been officially diagnosed. Another 35% of Americans over the age of 20, or 79M individuals, have pre-diabetes and are at risk. 1

About Glooko
Glooko™ is an innovative Silicon Valley startup with a unique solution for people with diabetes . In November 2011, Glooko launched the Glooko MeterSync Cable and Glooko Logbook app for iOS devices . The products enable people with diabetes to easily collect and view the information needed to help them successfully control their blood glucose readings. It has been hailed by users and industry influencers for it s ease-of-use and ability to provide cont ext to daily data collected by people with diabetes. The company was founded in June 2010 by technologist, Yogen Dalal, diabetes healthcare executive, Anita Mathew and mobile and web app developer, Sundeep Madra. Each founder and many on the Glooko team have a personal connection to diabetes. This is just the beginning on the mission to help people with diabetes live life while effortlessly managing their diabetes. For more information: www.glooko.com/purchasehttps://glooko.com/.

About Roche
Headquartered in Basel, Switzerland, Roche is a leader in research – focused healthcare with combined strengths in pharmaceuticals and diagnostics. Roche is the world’s largest biotech company with truly differentiated medicines in oncology, virology, inflammation, metabolism and CNS. Roche is also the world leader in in-vitro diagnostics, tissue – based cancer diagnostics and a pioneer in diabetes management. Roche’s personalized healthcare strategy aims at providing medicines and diagnostic tools that enable tangible improvements in the health, quality of life and survival of patients. In 2010, Roche had over 80,000 employees worldwide and invested over 9 billion Swiss francs in R&D. The Group posted sales of 47.5 billion Swiss francs. Genentech, United States, is a wholly owned member of the Roche Group. Roche has a majority stake in Chugai Pharmaceutical, Japan. For more information: www.roche.com .

About Roche Diabetes Care
Roche Diabetes Care is a pioneer in the development of blood glucose monitoring systems and a global leader for diabetes management systems and services. For more than 35 years, the ACCU-CHEK brand has been dedicated to enable people with diabetes to live life as normal and active as possible as well as to empower healthcare professionals manage their patients’ condition in an optimal way. Today, the ACCU-CHEK portfolio offers people with diabetes and healthcare professionals innovative products and impactful solutions for convenient, efficient and effective diabetes management. It encompasses blood glucose meters, insulin delivery systems, lancing devices, data management systems and education programs – contributing to an improved medical outcome. For more information: www.accu-chek.com .

1 US Dept of HHS. (2011). National Diabetes Statistics. NIH Publication, 11 (3892)

For more information please contact

Anita Mathew
Glooko
Phone: +1 650 395 8476
E – mail: [email protected]

Todd Siesky
Roche Diabetes Care
Roche Diagnostics
Phone: +1 317 521 3966
E – Mail: [email protected]

or visit
www.accu-chek.com
www.glooko.com

All trademarks used or mentioned in this release are protected by law

$3.5 Million Series A Financing Will Fuel Product Innovation, Market Penetration

January 30, Palo Alto, California – Glooko, provider of a unique hardware device and app solution for people with diabetes, today announced a $3.5 Series A financing round, led by The Social+Capital Partnership, with participation from existing investors. The funds will enable Glooko to rapidly deliver new releases of its integrated solution and extend its reach to the 25 million people living with diabetes in the U.S. today.

Chamath Palihapitiya, Founder+Managing Partner of The Social+Capital Partnership (“s23p”) joins the board.
Joining s23p in Glooko’s financing is a stellar list of investors including Silicon Valley luminaries such as Bill Campbell, Vint Cerf, Judy Estrin and Andy Hertzfeld; seasoned investors such as Venky Harinarayan of Cambrian Ventures and Russell Hirsch of Prospect Venture Partners; and Xtreme Labs, a Canadian mobile applications development firm.

Glooko’s breakthrough solution consists of the Glooko MeterSync Cable that plugs into most standard self-monitoring blood glucose meters and the Glooko Logbook app for iOS devices that automatically creates a digital logbook of readings, allows users to review daily blood sugar levels, annotate them and share the results with their physician. The product debuted in November, and has since been hailed by users and bloggers for it’s ease-of-use and ability to provide context to daily data collected by people with diabetes.

“Proactive and ongoing self-management of one’s health can now be a reality using mobile devices and well-designed  software,” said Palihapitiya. “Glooko has made important progress in helping individuals better manage one of the most pervasive diseases of our generation.”

In related news, Glooko today released a new version of the Glooko Logbook app that supports the Bayer’s Breeze 2 meter, including a real-time food database, a 30-day logbook, and availability in Canada. Glooko Logbook can be downloaded from the iTunes App store and the Glooko MeterSync cable can be purchased from www.amazon.com in the US and www.well.ca in Canada.

“By recruiting a team of experts and employing an efficient development process, we were able to deliver an FDA Class 1, full-featured solution in 1 year and with $1 million in seed capital,” said Yogen Dalal, Glooko co-founder and chairman and a seasoned Silicon Valley venture capitalist. “ With the ubiquity of mobile devices and the user drive toward the quantified self, we are excited about the potential to transform the lives of people with diabetes.

About Glooko
Glooko™ is an innovative Silicon Valley startup with a unique solution for people with diabetes. Our products enable users with smartphones to easily collect and view the information needed to help them successfully control their blood glucose levels. For more information, visit www.glooko.com or email [email protected]

About The Social+Capital Partnership
The Social+Capital Partnership is a stage-agnostic fund focused on backing exceptional entrepreneurs in the areas of healthcare, education, financial services and internet technologies. The Social+Capital Partnership is based in Palo Alto, CA.